期刊文献+

放射性粒子植入、放疗对荷VX2瘤兔细胞因子水平的影响 被引量:1

Comparative study of the influence of radioactive seeds implantation and radiotherapy on cytokine of VX2 tumor rabbits
原文传递
导出
摘要 目的探讨放射性粒子与放疗对机体细胞因子的影响。方法健康雄性大白兔60只,随机分为放射性粒子组、放疗组、对照组各20只,移植VX2瘤株后12d,对各实验组动物分别进行放射性粒子植入、X射线外照射放疗,对照组不治疗,同时监测血清白细胞介素2(IL-2)、IL-6、IL-8、肿瘤坏死因子(TNF)、胰岛素样生长因子(IGF)水平的变化。结果实验动物生存期较对照组延长15d左右。血清IL-2、IL-8逐渐降低,降低幅度对照组〉放射治疗组〉放射性粒子组;IL-6、IGF逐渐增高,增高幅度对照组〉放射治疗组〉放射性粒子组;TNF逐渐增高,放射治疗组和放射性粒子组变化明显,而对照组变化最小。结论荷瘤动物的免疫功能呈低下状态,放射性粒子和放疗对细胞因子影响不大,而放射性粒子影响更小;放射性粒子、放疗对VX2瘤治疗效果好。 Objective To discuss the influence of radioactive seeds implantation and radiotherapy on VX2 tumor cytokine. Methods 60 male New Zealand White rabbits were randomly divided into 3 groups, 20 for radioactive seeds implantation group, 20 for radiotherapy group, and 20 for control group. After 12 d the implantation with the VX2 soft tumor, radioactive seeds implantation and radiotherapy were performed separately, the control group underwent no therapy. IL-2, IL-6, IL-8, TNF and IGF were measured. Results The survival periods of experimental group were 15 d longer than the control group. The concentration of IL-2, IL-8 in serum decreased gradually, the decreasing extent control〉radiotherapy〉radioactive seeds implantation; the concentration of IL-6, IGF raised gradually, rising extent control〉radiotherapy〉radioactive seeds implantation. Conclusions The immune system of rabbits with VX2 tumor were suppressed, there is little influence of radioactive seeds implantation and radiotherapy on cytokine. Radioactive seeds implantation and radiotherapy are effective methods to treat VX2 tumor.
出处 《国际放射医学核医学杂志》 2007年第4期251-254,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 近距离放射疗法 放射疗法 白细胞介素 肿瘤坏死因子 胰岛素样生长因子 Brachytherapy Radiotherapy Interleukin Tumor necrosis factor Insulin like growth factor Rabbits
  • 相关文献

参考文献6

二级参考文献21

  • 1Conomus JS,Hoban M,Lee JD,et al. Production of tumor necrosis factor alpha and interferon gamma in interleukine-2 treated melanoma patients:correlation with clinical toxicity[J].Cancer Immunol Immunother,1991,34:49-52.
  • 2Oldham RK.Biologicals and biological response modifiers:fourth modality of cancer treatment[J]. Cancer Treat Rep. 1984 Jan;68(1):221-32.
  • 31 Alan F,Holmer.The century of biology begins with 369 biotechnology medicines in testing for more than 200 diseases[M].New medicine in development biotechnology,2000:1.
  • 4Frucht DM. IL-23:a cytokine that acts on memory T cells[J].Sci STKE. 2002 Jan 8;2002(114):PE1. Review.
  • 5Fujita T, Tamura T, Yamada H, et al. Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice[J].J Drug Target. 1997;4(5):289-96.
  • 6Alan F.Holmer.The century of biology begins with 369 biotechnology medicines in testing for more than 200 disease[M]. New medicine in development Biotechnology,2000:1-5.
  • 7Ettinghausen SE,Moore JG,White DE,et al.Hematalogic effects of immunotherapy with lymphokine-activated killer cells and recombinant interleukine-2 in cancer patients[J].Blood,1987,69(6):1654-1660.
  • 8Lee RE,Lotze HM,Skibber JM,et al. Cardiorespiratory effects of immunotherapy with interleukine-2[J]. J Clin Oncol,1989,7(1):7-20.
  • 9Yoshikawa H. Advanced Drug Deliv Rev,1997,28(2):239-251.
  • 10Crow J,Slavin G,Kreel L.Pulmonary metastasis: a pathologic and radiologic study.Cancer ,1981,47:2595-2602.

共引文献84

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部